Source: International Congress 2018 – New modalities in asthma treatment
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Kozlova (Chita State Medical Academy of Ministry of Health, Chita, Russian Federation), A. Akulova (Chita State Medical Academy of Ministry of Health, Chita, Russian Federation), O. Stepanova (Chita State Medical Academy of Ministry of Health, Chita, Russian Federation), K. Shapovalov (Chita State Medical Academy of Ministry of Health, Chita, Russian Federation), S. Lukyanov (Chita State Medical Academy of Ministry of Health, Chita, Russian Federation), O. Rosenberg, (Russian Research Center of Radiology and Surgery Technologies, St. Petersburg, Russian Federation). SURFACTANT THERAPY IN PATIENTS WITH SEVERE UNCONTROLLED BRONCHIAL ASTHMA. 1922

Member's Comments

No comment yet.

Related content which might interest you: PECULIARITIES OF CYTOKINE DYNAMICS IN PATIENTS WITH BRONCHIAL ASTHMA Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018 FOLLOW-UP OF PATIENTS WITH SEVERE COVID-19 PNEUMONIA AND TORPID EVOLUTION Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia Year: 2021 GLN27GLU POLYMORPHISM IN THE ß2-ADRENERGIC RECEPTOR GENE AND THE RISK OF ARTERIAL HYPERTENSION IN PATIENTS WITH BRONCHIAL ASTHMA Source: International Congress 2018 – Physiological and biological insights in asthma Year: 2018 BRONCHIAL MICROBIOME IN PATIENTS WITH LUNG CANCER Source: International Congress 2018 – Lung cancer: new aspects in diagnosis and management Year: 2018 SYSTEMIC EFFECT OF CONTINUOUS TREATMENT WITH AZITHROMYCYN IN PATIENTS WITH SEVERE COPD AND FREQUENT EXACERBATIONS Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights Year: 2019 A RESPIRATORY TELEREHABILITATION PROGRAM AS MAINTENANCE  IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE Source: International Congress 2018 – Let’s interact and discuss the hot topics in pulmonary rehabilitation Year: 2018 CARDIOPULMONARY EXERCISE TESTING PREDICTING POSTOPERATIVE MORBIDITY IN PATIENTS WITH PULMONARY RESECTION Source: Virtual Congress 2020 – Advances in lung function practice Year: 2020 PROTEOMIC ANALYSIS OF BLOOD SERUM OF CHILDREN WITH BRONCHIAL ASTHMA Source: International Congress 2019 – Asthma biomarkers, diagnostics and risk factors Year: 2019 DIAGNOSTICS, THERAPY, COURSE AND RESULTS IN PATIENTS WITH CHRONIC EXTRINSIC ALLERGIC ALVEOLITIS. Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children Year: 2020 QUALITY OF LIFE OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND THEIR CAREGIVERS Source: Virtual Congress 2020 – Organising respiratory disease management in primary care Year: 2020 LONG-TERM FOLLOW-UP OF PATIENTS WITH SYSTEMIC SCLEROSIS AND NORMAL OR BORDERLINE PULMONARY PRESSURES Source: Virtual Congress 2020 – Epidemiology and treatment of pulmonary arterial hypertension Year: 2020 EXCESS MORTALITY IN PATIENTS WITH ASTHMA ON LONG-ACTING β2-AGONISTS Source: Eur Respir J 2007; 29: 823 Year: 2007 UTILITY OF THE HIGH FLOW WITH NASAL CANNULA IN THE DECANULATION OF TRAQUEOTOMIZED PATIENTS DURING AN EPISODE OF ACUTE RESPIRATORY INSUFFICIENCY. Source: International Congress 2018 – New tools for managing respiratory failure Year: 2018 PULMONARY HYPERTENSION IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS ON ANTI-FIBROTIC TREATMENT WITH PIRFENIDONE OR NINTEDANIB: CLINICAL EVALUATION AND PROGNOSTIC IMPACT Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 ORAL MORPHINE IS SAFE IN SYMPTOMATIC PATIENTS WITH FIBROTIC INTERSTITIAL LUNG DISEASES Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia Year: 2019 PSYCHOLOGICAL FACTORS PREDICTIVE OF QUALITY OF LIFE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE Source: Virtual Congress 2020 – Prognosis and integrated management of COPD Year: 2020 PREVALENCE AND CHARACTERISTICS OF PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS ADMITTED FOR PNEUMONIA ACQUIRED IN THE COMMUNITY. Source: Virtual Congress 2020 – What is hot in idiopathic pulmonary fibrosis? Year: 2020 SYSTEMIC INFLAMMATION IN PATIENTS WITH STABLE NON-CYSTIC FIBROSIS BRONCHIECTASIS Source: Virtual Congress 2021 – Bronchiectasis Year: 2021 PLEURAL EFFUSION IN PATIENTS WITH COMMUNITY ACQUIRED PNEUMONIA Source: Virtual Congress 2020 – Antibiotic therapy for pneumonia and pleural infections Year: 2020 ONE YEAR MORTALITY IN PATIENTS WITH PNEUMOCOCCAL BACTERAEMIC COMMUNITY ACQUIRED PNEUMONIA: ROLE OF THREE PNEUMONIA SEVERITY SCORES Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers Year: 2017